Document Fragment View
Fragment Information
Showing contexts for: formative mark in Pfizer Products, Inc. vs Renovision Exports Pvt. Ltd. on 1 May, 2024Matching Fragments
an adoption was clearly intended to ride upon the goodwill and reputation of Plaintiff's mark. The Court has, in the preceding paragraphs, already ruled that Defendants' trademark "VIGOURA" and its formative marks have a high likelihood of causing confusion, particularly in view of the fact that the impugned mark is being issued for similar pharmaceutical products. There is thus apparent danger of the public getting confused, or at least wondering, whether the products marketed under the impugned "VIGOURA" mark are associated with the products of Plaintiff.